PDX INSIGHTS
PIONEERING CANCER RESEARCH
Drug Studies Summary

Collections:
Study ID:
Study Title:
Treatments:

Study:  Tolinapant Efficacy Study
Description: 
Treatments: Tolinapant
Study:  Birinapant Efficacy Study
Description: 
Treatments: Birinapant
Study:  VFoundation Study
Description: 
Treatments: AC, AC+C188-9, C188-9, Carbo, Carbo+C188-9, Doc20, Doc20+C188-9, Pac, Pac+C188-9
Study:  Legacy 2013 - PDX Efficacy Study
Description: 
Treatments: Paclitaxel, Doxorubicin, Doxorubicin+Cyclophosphamide
Study:  Legacy 2017 - PDX Efficacy Study
Description: 
Treatments: 5-Fluorouracil, MK-1775, Olaparib, Ponatinib, Doxorubicin, AZD8186, Palbociclib, TAK228, Palbociclib+AZD8186, Palbociclib+TAK228, Apitilosib, Everolimus, Gemcitabine, Paclitaxel, Lapatinib
Study:  PPR Study
Description: 
Treatments: Birinapant, Tolinapant